Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07041489 · ClinicalTrials.gov registry record · NA
Evaluating the Combined Use of Supplement and Serum in Promoting Hair Growth in Women With Self-perceived Thinning Hair
A NA study of Hair Thinning, sponsored by The Center for Clinical and Cosmetic Research.
- Recruiting
- Registry status
- NA
- Development phase
- 85
- Enrollment target
- 2
- Study locations
NCT07041489 is a NA study of Hair Thinning that is actively recruiting participants, run by The Center for Clinical and Cosmetic Research. The registered enrollment target is 85 participants, above the 57-participant average among 10 other Hair Thinning trials with a reported enrollment target (49% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT07041489, a NA study of Hair Thinning, is actively recruiting participants, sponsored by The Center for Clinical and Cosmetic Research.
- RECRUITING
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial is to test how safe and effective it is to improve hair growth using an active gummy and serum combination treatment when compared to an inactive treatment combination in women with self-perceived thinning hair. The main questions this trial aims to answer are: * to confirm using photograph analytics, how much hair growth has increased in a marked area when using active treatment versus inactive treatment, and * participants assessment and satisfaction with the hair growth using scaled assessments. Participants who qualify will be asked to complete 6 to 7 visits after voluntarily consent has been given. The study is divided into two parts. In Part A participants will be randomly given either active or inactive treatment to use over 3 months. After 3 months, all participants will enter Part B of the study and will be given active treatment to use over the final 6 months of the study.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Active Comparator- Xtressé™ Supplement and Serum
- DIETARY_SUPPLEMENT Placebo Comparator- Placebo Supplement and Serum
Study Locations (2)
Alabama
- Skin Wellness Dermatology - Birmingham
Florida
- Center for Clinical and Cosmetic Research - Aventura
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2025-05-20 |
| Est. Completion | 2026-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07041489
The ClinicalTrials.gov registry entry for NCT07041489 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 57-participant average among 10 other Hair Thinning trials with a reported enrollment target (49% higher). The listed sponsor is The Center for Clinical and Cosmetic Research, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hair Thinning appearing as the primary indexed condition, and to 2 interventions - of which Active Comparator- Xtressé™ Supplement and Serum is the first listed.
NCT07041489 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Alabama, Florida.
Frequently Asked Questions
What is clinical trial NCT07041489 about?
NCT07041489 is a clinical study titled "Evaluating the Combined Use of Supplement and Serum in Promoting Hair Growth in Women With Self-perceived Thinning Hair". The goal of this clinical trial is to test how safe and effective it is to improve hair growth using an active gummy and serum combination treatment when compared to an inactive treatment combination in women with self-perceived thinning hair. The main questions this trial aims to answer are: * to...
What is the current status of trial NCT07041489?
This trial is currently recruiting. It is a NA study. The enrollment target is 85 participants. The study started on 2025-05-20. Estimated completion is 2026-03-30.
What conditions does trial NCT07041489 study?
This clinical trial studies the following conditions: Hair Thinning.
What interventions are being tested in trial NCT07041489?
The interventions under investigation include: Active Comparator- Xtressé™ Supplement and Serum (DIETARY_SUPPLEMENT), Placebo Comparator- Placebo Supplement and Serum (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07041489?
This trial is sponsored by The Center for Clinical and Cosmetic Research, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07041489 being conducted?
This trial has 2 study locations across Alabama, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hair Thinning
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Clinical Trial to Examine the Efficacy of a Dietary Supplement to Improve the Health and Appearance of Hair.
ACTIVE NOT RECRUITING · NA
-
A Clinical Trial to Examine the Efficacy of a Supplement to Support Healthy Hair and Skin
ACTIVE NOT RECRUITING · NA
-
Efficacy and Safety of TargetCool + Benev Exosomes in Patients With Hair Thinning
ACTIVE NOT RECRUITING · NA
-
The Effects of an Oral Hair Supplement on Hair Density, Growth, and Microbiome
ACTIVE NOT RECRUITING · NA
-
Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Women With Thinning Hair
COMPLETED · NA
-
A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.